Symptom burden and clinical profile of COVID-19 deaths: a rapid systematic review and evidence summary.


Journal

BMJ supportive & palliative care
ISSN: 2045-4368
Titre abrégé: BMJ Support Palliat Care
Pays: England
ID NLM: 101565123

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 22 04 2020
accepted: 27 04 2020
pubmed: 30 5 2020
medline: 1 12 2020
entrez: 30 5 2020
Statut: ppublish

Résumé

The spread of pandemic COVID-19 has created unprecedented need for information. The pandemic is the cause of significant mortality and with this the need for rapidly disseminated information for palliative care professionals regarding the prevalence of symptoms, their intensity, their resistance or susceptibility to symptom control and the mode of death for patients. We undertook a systematic review of published evidence for symptoms in patients with COVID-19 (with a specific emphasis on symptoms at end of life) and on modes of death. Inclusion: prospective or retrospective studies detailing symptom presence and/or cause or mode of death from COVID-19. 12 papers met the inclusion criteria and gave details of symptom burden: four of these specifically in the dying and two detailed the cause or mode of death. Cough, breathlessness, fatigue and myalgia are significant symptoms in people hospitalised with COVID-19. Dyspnoea is the most significant symptom in the dying. The mode of death was described in two papers and is predominantly through respiratory or heart failure. There remains a dearth of information regarding symptom burden and mode of death to inform decisions regarding end-of-life care in patients dying with COVID-19. Rapid data gathering on the mode of death and the profile of symptoms in the dying and their prevalence and severity in areas where COVID-19 is prevalent will provide important intelligence for clinicians. This should be done urgently, within ethical norms and the practicalities of a public health, clinical and logistical emergency.

Identifiants

pubmed: 32467101
pii: bmjspcare-2020-002368
doi: 10.1136/bmjspcare-2020-002368
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

381-384

Subventions

Organisme : Marie Curie
ID : MCCC-FCO-11-C
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Paul Keeley (P)

Palliative Care Team, Glasgow Royal Infirmary, Glasgow, UK paul.keeley@glasgow.ac.uk.
MVLS, University of Glasgow, Glasgow, UK.

Deans Buchanan (D)

Palliative Medicine & Supportive Care, NHS Tayside, Dundee, UK.

Clare Carolan (C)

University of the Highlands and Islands, Inverness, Highland, UK.

Lara Pivodic (L)

End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Brussels, Belgium.

Simon Tavabie (S)

Marie Curie Hospice Hampstead, London, UK.

Simon Noble (S)

Marie Curie Palliative Care Research Centre, Cardiff University, Cardiff, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH